Skip to main content
. 2012 Jul 17;7(7):e37659. doi: 10.1371/journal.pone.0037659

Figure 2. Arg389 homozygotes vs. Gly389 carriers in different ethnics: the response to β-blockers.

Figure 2

(A) the reduction of HR; (B) the improvements of LVEF; (C) the improvements of LVEDd/v; (D) the improvements of LVESd/v. Gly389 carriers: including Arg389Gly and Gly389 homozygotes; CI: confidence interval; HR: heart rate; LVEF: left ventricular ejection fraction; LVEDd/v: left ventricular end-diastolic diameter/volume; LVESd/v: left ventricular end-systolic diameter/volume.